Navigation Links
Roche in Medical News
Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
PORTON DOWN, England, July 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on 15 July 2009,...Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
Roche to fund evaluation of Raptor's proprietary NeuroTrans(TM) technology NOVATO, Calif., June 9 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has entered a collaboration and licensing agreement with Roc...moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
MEXICO CITY, SAO PAULO and PHILADELPHIA, May 20 /PRNewswire/ -- moksha8, Inc. announced today that it has expanded its strategic partnership with Roche to commercialize an additional portfolio of products in Mexico currently generating sales of $140 million USD. moksha8 will commercialize pr...Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15
CHAPEL HILL, N.C., May 7 /PRNewswire/ -- When the unpredictable influenza season returns in the fall, health care officials warn that the seemingly lessening threat of the H1N1 outbreak may worsen. Operating under pandemic contingency plans already, nearly one-third of companies do not have a po...Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
SAN DIEGO, April 1 /PRNewswire-FirstCall/ -- Gen-Probe (Nasdaq: GPRO ) announced today that the Company, along with its co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular Systems, Inc., has prevailed in its arbitration with Digene (now Qiagen) concerning the Company's supply and purcha...Beauty Care Sales and Marketing Veteran to Drive International Retail Expansion, With Near Term Focus on Top Selling AcneFree Product Group and New WrinkleFree Brand Line Extension IRVINE, Calif., Jan. 21 /PRNewswire/ -- University Medical Pharmaceuticals, a leading developer and distributo...
Roche in Medical Technology
LEUVEN, Belgium and LUND, Sweden, January 26 /PRNewswire-FirstCall/ --
ThromboGenics NV (EURONEXT:THR) and BioInvent International AB (OMXS:BINV)
announce today that they have received a technology transfer success fee of
EUR5 million from Roche under the terms of their strategic alliance for ...
SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that Roche has dosed the first patient in a Phase 1 pharmacokinetic clinical trial with...
DENVER, Sept. 10 /PRNewswire-USNewswire/ -- National Jewish Health and Roche Diagnostics Corporation have reached a strategic agreement to pursue opportunities in the growing field of molecular diagnostics. This partnership will combine National Jewish's expertise in clinical testing and care ...
SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that Roche has dosed the first patient in a Phase 1 pharmacokinetic clinical trial with...
Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
- Amendment Results in Accelerated Payments of $8.5 Million - MONTVALE, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced that it has amended its nicotinic alpha-7 receptor agonist agreement with Roche to expand the Phase 2 development ...DENVER, Sept. 10 /PRNewswire-USNewswire/ -- National Jewish Health and Roche Diagnostics Corporation have reached a strategic agreement to pursue opportunities in the growing field of molecular diagnostics. This partnership will combine National Jewish's expertise in clinical testing and care ...
New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
BASEL, Switzerland, May 15 /PRNewswire/ -- Patients with breast or colorectal cancer, two of the world's most common cancers, can expect further treatment advances with Avastin(R) (bevacizumab) and Herceptin(R) (trastuzumab) following new data that is being presented at the 44th American Socie...Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
- Establishes Plan for Biomarker Study - MONTVALE, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced that it plans to conduct a clinical study of MEM 3454, the Company's lead nicotinic alpha-7 partial agonist, on two biomarker...Roche in Medical Products
Microbumin Microalbumin Control
Description:... Microbumin is a two-level control compatible with popular strips such as Clinitek Microalbumin Reagent Strips and roche Micral test strips. This control is also suitable for turbidimetric immunoassays using AU Series, Bayer Clinitek 50, 100 and DCA 2000, Cobas, Diasorin...Company:Quantimetrix Corporation
Description:... The roche CARDIAC proBNP assay is a rapid and accurate bedside test for the easy to u...oth speed and accuracy profit from a test combining speed (measuring time roche CARDIAC proBNP assay = 12 minutes. In emergency departments Point of Care T...
Company:Roche Diagnostics
Roche COMPACT 3 Blood Gas Analyzer
Description:...fastest blood gas analyzers for critical and intensive care situations on the market. Equally suitable for neonatology and lung function testing. The roche COMPACT 3 offers a quick and reliable assessment of acid-base status and oxygen supply from whole blood, plasma or serum....Company:Roche Diagnostics
Roche OMNI S Blood Gas Analyzer
Description:... roche OMNI S is the next generation Critical Care Analyzer completes and extends the roche product portfolio for Hospital Point of Care applications. The modular conc...Company:Roche Diagnostics
Description:... The LightCycler 2.0 System is the newest real-time PCR instrument offered by roche Applied Science. This new instrument offers six detection channels that provide fluorescence detection at 530, 560, 610, 640, 670, and 710nm. Perform ...
Company:Roche Applied Science
Emit® 2000 (Convenience Pack) Phenytoin Assay
Description:... enzyme immunoassay intended for use in the quantitative analysis of phenytoin in human serum or plasma. Kits are packaged specifically for use on the roche COBAS MIRA, COBAS MIRA S, and COBAS MIRA Plus chemistry systems...Company:Dade Behring, Inc.
Roche in Biological News
Washington University increases fleet of Roche Genome Sequencer FLX Systems
INDIANAPOLISThe Genome Sequencing Center at Washington University School of Medicine increased its sequencing capacity with an agreement to acquire five additional Genome Sequencer FLX Systems from Roche Diagnostics. With a total of eight Genome Sequencer FLX Systems, the Genome Sequencing Cent...Scientists decoding genomic sequences of H1N1 using isolates from outbreak in Argentina
...are working with Argentina's National Institute of Infectious Diseases, the National Administration of Laboratories and Health Institutes (ANLIS), and roche 454 Life Sciences to decode the complete genomic sequences of influenza pandemic (H1N1) 2009 virus from patients with severe respiratory disease. The ...Landmark project to map genomics of complex ant systems
... Giga-base Grant Program for DNA sequencing and transcriptome analysis from roche Applied Sciences, Gerardo put together a project to not only sequence ant g...ing, and one ancient, more primitive species. Entering new territory roche will sequence the DNA using its proprietary high-throughput genome sequenci...Another JDRF partner moves research forward with collaboration agreement for diabetes treatment
...stry partner Bayhill Therapeutics Inc., based in California, entered into a collaboration agreement with Genentech, Inc., a wholly owned member of the roche Group, to further develop and potentially commercialize a novel antigen-specific immunotherapeutic designed to reverse the immune response that causes...Rapid approach to identify influenza A virus mutations and drug resistance developed
..., Development and Research), in collaboration with roche NimbleGen. The system, which combines a novel g...virus is evolving," said Gerd Maass, Ph.D., CEO of roche NimbleGen. GIS scientists used NimbleGen array...source and to globally monitor the SARS virus. roche NimbleGen's custom-developed microarrays: The ...CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda
...ee Foernzler, Ph.D., Biomarker-Experimental Medicine Leader, F. Hoffmann-La roche AG Alberto Gutierrez, Ph.D., Deputy Director, Office of In Vitro Dia...P.H., Head, Medical Genomics & Vice President, Research, F. Hoffmann-La roche AG Helen M. Moore, Ph.D., Director, Biospecimen Research Network, Na...Roche in Biological Technology
Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer
Zdechlik was Founding member of the U.S. Clinical Molecular Diagnostic Group NEW YORK, July 23 /PRNewswire-USNewswire/ -- Exosome Diagnostics, Inc., the developer of non-invasive molecular oncology diagnostics to aid in early cancer detection and therapeutic selection, announc...Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
MADISON, Wis., July 1 /PRNewswire/ -- Cellular Dynamics International (CDI) and Roche announced today a significant expansion of their existing agreement to test drug development candidates for their potential to cause cardiotoxicity, or damage to heart tissue. The two-year collaboration a...BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services
BEIJING, April 6 /PRNewswire/ -- BioDuro announced today that they have entered into a strategic partnership with Roche to support discovery phase research efforts at Roche's global research sites. BioDuro will provide research services in the areas of discovery chemistry and biology, which can he...Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
BETHESDA, Md., Feb. 23 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that Dr. Kapil Dhingra has joined its Board of Directors, effective as ...PRINCETON, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announced today that they and their development partner, Roche, have agreed with the FDA on the final design for a phase 2b trial with R7128, a nucleoside inhibitor of hepatitis C (HCV), slated to initiate in the...
Axial Biotech Appoints Retired Roche Diagnostics Executive to Board
Experienced leader will provide commercialization expertise to company SALT LAKE CITY, Oct. 14 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostic technologies, announced today the appointment of William L. Lister as the ne...Roche in Biological Products
In Situ Cell Death Detection Kit, Fluorescein from Roche Applied Science
Description: ...Company:Roche Applied Science
MagNA Pure LC Instrument from Roche Applied Science
Description: ...Company:Roche Applied Science
SYBR Green I Nucleic Acid Gel Stain from Roche Applied Science
Description: ...Company:Roche Applied Science
GC-RICH PCR System from Roche Applied Science
Description: ...Company:Roche Applied Science
GC-RICH PCR System from Roche Applied Science
Description: ...Company:Roche Applied Science
Propidium iodide; solution (Available only in the U.S.) from Roche Applied Science
Description: ...Company:Roche Applied Science
Roche in Biological Definition
...7.
^ ORTHOCLONE OKT 3 Information page at Ortho Biotech . Retrieved 2005-03-10.
^ ZENAPAX (daclizumab) Information page at roche Pharmaceuticals . Retrieved 2005-03-10.
^ Novartis product page for Simulect (basiliximab for injection) . Retrieved 2005-03-09.
...
...everal high-profile lawsuits related to the technique, including most famously a lawsuit brought by DuPont . The pharmaceutical company Hoffmann-La roche purchased the rights to the patents in 1992 and currently holds them. PCR in practice Figure 1 : PCR machine PCR is used to...
...everal high-profile lawsuits related to the technique, including most famously a lawsuit brought by DuPont . The pharmaceutical company Hoffmann-La roche purchased the rights to the patents in 1992 and currently holds them. PCR in practice Figure 1 : PCR machine PCR is used to...
Roche in Biological Dictionary
...NA, siRNA or duplex RNAi, oligonucleotides, and RNA into eukaryotic cells for a ... More information on Cutting Edge Transfection Reagents from roche Applied Science ... Web Seminar—Challenges and Transfection Technologies in the Study of Cellular ... Transfection summary with 4 pages of ency...
...es for restriction enzymes , a.k.a. restriction endonucleases, in DNA sequences. ... With more than 115 restriction enzymes now available, roche Applied Science provides. restriction enzymes that span a wide range of recognition sequences, ... We tested 30 popular Promega restriction ...
...ion and genetic ... From our vast line of reporter gene assays, you can choose ... A sample of the reporter gene assay kits available from roche Molecular Biochemicals. ... Reporter Genes and Proteins ... reporter proteins in use: b-galactosidase (encoded by the bacterial gene lacZ...
...es for restriction enzymes , a.k.a. restriction endonucleases, in DNA sequences. ... With more than 115 restriction enzymes now available, roche Applied Science provides. restriction enzymes that span a wide range of recognition sequences, ... We tested 30 popular Promega restriction ...
...ion and genetic ... From our vast line of reporter gene assays, you can choose ... A sample of the reporter gene assay kits available from roche Molecular Biochemicals. ... Reporter Genes and Proteins ... reporter proteins in use: b-galactosidase (encoded by the bacterial gene lacZ...
Other TagsOther Contents
NumberingOsmotherapyPharmaconomistPhotomedicinePolysomnographicProteopathySomatoSuttonSwankThickenedThymocyteUltradianUnguentPrize
(Date:6/19/2013)... 2013 HASCO Medical, Inc. (OTCBB: ... intent to purchase privately held Auto Mobility Sales, ... wheelchair accessible vehicle sales, service and rentals in ... Inc compliments and expands HASCO's strategy of becoming ... dealers . The acquisition is subject to customary ...
(Date:6/19/2013)... Nashville, TN (PRWEB) June 19, 2013 ... the appointment of Dr. John Baxter to Vice President, ... currently serves as Director, Mental Health Services for CCA. ... "It is an honor and great privilege to lead ... offers the unique opportunity to serve society and our ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Brain not ... DC, MS, explains why such seemingly minor brain problems ... concussions are vital red flags. They indicate the brain ... multiple sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and other neurological ... in June 2013 by Elephant Press is now available ...
(Date:6/19/2013)... 19, 2013 Strict rules for ... 2013, Orriant is launching a new tool to ... compliance with regulations. New HHS regulations will ... incentives if their employer offers outcome-based, health-contingent, compliant ... compliant with these standards for nearly a decade. ...
(Date:6/19/2013)... Today, Zane Benefits, Inc. published new ... Zane Benefits, which provides comprehensive and flexible alternatives to ... defined contribution and health reimbursement arrangement ... part of the Affordable Care Act (ACA), health insurance ... through new state health insurance exchanges. , Most importantly, ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3[0] HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc.[0] CCA Names Dr. John Baxter Vice President, Health Services[0] Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later[0] New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations[0] Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange
(Date:6/19/2013)... 2012, the European Medicines Agency (EMA) approved the ... ever gene therapy for clinical use in the ... developed AAV-LPL S447X for the treatment of a ... (LPLD) which affects approximately one or two out ... life-threatening inflammations of the pancreas. Afflicted individuals carry ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
(Date:6/18/2013)... June 18, 2013 Joshua Obar, Ph.D., Department ... been honored with a 2013 ICAAC Young Investigator Award ... of immunological memory responses to infection. , Obar ... in 2001 and went on to complete his Ph.D. ... He performed his Ph.D. thesis research in Edward ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2The American Society for Microbiology honors Joshua Obar 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |